Health Condition 1: L811- Chloasma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of all sexes between 18-50 years Clinically diagnosed patient of Melasma Female of reproductive age group agree to use acceptable form of birth control during study (except IUCD and hormonal contraception) Patient willing to sign the informed consent and to complete the study
Exclusion criteria
Exclusion criteria: Pregnant and lactating females Females using OCP (oral contraceptive pills) IUCD and hormonal contraception Patient having other skin diseases like acne dermatitis urticaria dermatophytosis Patients who have a known history or clinically relevant allergy in particular to any component of study medication Having systemic disorders such as hepatic and renal insufficiency endocrine disorders malignant or premalignant lesions immunodeficiency diseases neurological and cardiac disorders Patient consuming alcohol or drug abuse Patient have taken topical or systemic treatment of melasma for last one month Patient receive any cosmetic procedure such as chemical peel laser ablation FRT or dermabrasion for last 3 months Not willing to sign informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Melasma severity index 2.Photography 3.Safety evaluationTimepoint: 1.on day 0, 21, 42 2.on day 0, 42 3.on day 0, 42 | — |
Secondary
| Measure | Time frame |
|---|---|
| MELASQOL (Melasma Quality of Life Scale)Timepoint: on Day 0, 42 | — |
Countries
India
Contacts
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital